We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02078674
Recruitment Status : Completed
First Posted : March 5, 2014
Last Update Posted : September 23, 2016
Department of Health and Human Services
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2015
  Study Completion Date : July 2015
  Certification or Request for Extension to Delay Results Submission: September 20, 2016